KidneyCal's profile picture. SickKids Peds Nephrology | PhD student | Toronto 🇨🇦 | Aspiring clinician-scientist | Adaptive clinical trials, trial emulation, and health admin data

Cal Robinson

@KidneyCal

SickKids Peds Nephrology | PhD student | Toronto 🇨🇦 | Aspiring clinician-scientist | Adaptive clinical trials, trial emulation, and health admin data

Cal Robinson gönderiyi yeniden yayınladı

Central venous catheter–related bloodstream infections (CRBSI) are common in children receiving hemodialysis & cause significant morbidity & healthcare costs. Read this Original Article on use of 4% tetrasodium EDTA (KiteLock™) to prevent CRBSI. link.springer.com/article/10.100…

Ped_Neph's tweet image. Central venous catheter–related bloodstream infections (CRBSI) are common in children receiving hemodialysis & cause significant morbidity & healthcare costs. Read this Original Article on use of 4% tetrasodium EDTA (KiteLock™) to prevent CRBSI.
link.springer.com/article/10.100…

Cal Robinson gönderiyi yeniden yayınladı

Steroid-sparing immunosuppression is used in 50% of children w/nephrotic syndrome, but rates & predictors of prolonged remission after cyclophosphamide & tacrolimus are uncertain. Read this Original Article for more. link.springer.com/article/10.100…

Ped_Neph's tweet image. Steroid-sparing immunosuppression is used in 50% of children w/nephrotic syndrome, but rates & predictors of prolonged remission after cyclophosphamide & tacrolimus are uncertain. Read this Original Article for more.
link.springer.com/article/10.100…

I have made the jump over to BlueSky - follow me there at the same handle @KidneyCal bsky.app/profile/kidney…


Cal Robinson gönderiyi yeniden yayınladı

AKI affects a growing number of children and neonates and is associated with high morbidity, mortality, and health care expenditure. In this issue of JASN, Robinson et al. present the findings of a large cohort study on the long-term outcomes of AKI in hospitalized children who…

JASN_News's tweet image. AKI affects a growing number of children and neonates and is associated with high morbidity, mortality, and health care expenditure. In this issue of JASN, Robinson et al. present the findings of a large cohort study on the long-term outcomes of AKI in hospitalized children who…

How can simulation be used to improve the design adaptive clinical trials? Read our review article just published in @JASN_News to find out! Big thanks to co-authors @DrRulanParekh @douyang3 @efan75 @BrianCuthberts8 and Anna Heath. journals.lww.com/jasn/citation/…


Cal Robinson gönderiyi yeniden yayınladı

Long-Term Kidney Outcomes after Pediatric AKI ca. 2024 from @JASN_News #Nephpearls #KidneyWk #BestofJASN #VisualAbstract by @nikkonephro 👉 pubmed.ncbi.nlm.nih.gov/39018120/

edgarvlermamd's tweet image. Long-Term Kidney Outcomes after Pediatric AKI ca. 2024 from @JASN_News 
#Nephpearls #KidneyWk #BestofJASN
#VisualAbstract by @nikkonephro 

👉 pubmed.ncbi.nlm.nih.gov/39018120/
edgarvlermamd's tweet image. Long-Term Kidney Outcomes after Pediatric AKI ca. 2024 from @JASN_News 
#Nephpearls #KidneyWk #BestofJASN
#VisualAbstract by @nikkonephro 

👉 pubmed.ncbi.nlm.nih.gov/39018120/

Amazing to see a childhood nephrotic syndrome RCT in the #ASNKids24@ASNKidney⁩ late breaking trials session! So exciting to see RCTs starting to emerge to improve treatment for these children

KidneyCal's tweet image. Amazing to see a childhood nephrotic syndrome RCT in the #ASNKids24 ⁦@ASNKidney⁩ late breaking trials session!  So exciting to see RCTs starting to emerge to improve treatment for these children

Cal Robinson gönderiyi yeniden yayınladı

Excellent poster by Cal Robinson et al on a target trial emulation of cyclophosphamide vs CNIs in #nephroticsyndrome ! #ASNKids24 @ASPNeph @ASNKidney

WendyHsiaoMD's tweet image. Excellent poster by Cal Robinson et al on a target trial emulation of cyclophosphamide vs CNIs in #nephroticsyndrome ! #ASNKids24 @ASPNeph @ASNKidney

Cal Robinson gönderiyi yeniden yayınladı

Using population-based health administrative databases, study investigators found that 1/3 of children with posterior urethral valves develop major adverse kidney events (death, kidney failure, or CKD) by early adulthood, compared with 1% of the general childhood population.…

JASN_News's tweet image. Using population-based health administrative databases, study investigators found that 1/3 of children with posterior urethral valves develop major adverse kidney events (death, kidney failure, or CKD) by early adulthood, compared with 1% of the general childhood population.…

Cal Robinson gönderiyi yeniden yayınladı

Long-Term Kidney Outcomes in Children with Posterior Urethral Valves #PUV @JASN_News ow.ly/Pqz450T4EnC


Children with posterior urethral valves are at long-term risk of CKD, kidney failure, and hypertension. One-third develop major adverse kidney events over median 16.6 year follow-up. Kidney health surveillance into adulthood with improved transition planning is needed!

KidneyCal's tweet image. Children with posterior urethral valves are at long-term risk of CKD, kidney failure, and hypertension.

One-third develop major adverse kidney events over median 16.6 year follow-up.  

Kidney health surveillance into adulthood with improved transition planning is needed!

I am thrilled to share our newest paper about long term outcomes in #PUV patients using @ICESOntario data, out today in @JASN_News! journals.lww.com/jasn/abstract/… Thanks for the great collaboration @KidneyCal @about__juliane @TimVanMieghem @JoanaRosaP @ChanchlaniRahul @ArmandoJLorenzo



Cal Robinson gönderiyi yeniden yayınladı

Long-Term Kidney Outcomes after Pediatric Acute Kidney Injury #AKI ow.ly/3G7F50SUxEV @JASN_News


Cal Robinson gönderiyi yeniden yayınladı

Meet IMPaCT Fellow @KidneyCal ! Through his research, Cal aspires to advance the evidence-based treatment of pediatric kidney diseases, prevent adverse long-term outcomes, and minimize disease burden. Learn more about Cal’s project here: impactrials.ca/cal-robinson

IMPaCTrials's tweet image. Meet IMPaCT Fellow @KidneyCal ! Through his research, Cal aspires to advance the evidence-based treatment of pediatric kidney diseases, prevent adverse long-term outcomes, and minimize disease burden.

Learn more about Cal’s project here:
impactrials.ca/cal-robinson

Cal Robinson gönderiyi yeniden yayınladı

Interested in learning how to design and operate clinical trials for pregnant people and kids? 🤰👶🧒 Apply for an IMPaCT training award at impactrials.ca/awardinfo! Applications are open now, so don't miss out – submit by 5 PM CT on October 18, 2024!

IMPaCTrials's tweet image. Interested in learning how to design and operate clinical trials for pregnant people and kids? 🤰👶🧒 
Apply for an IMPaCT training award at impactrials.ca/awardinfo! 
Applications are open now, so don't miss out – submit by 5 PM CT on October 18, 2024!

Cal Robinson gönderiyi yeniden yayınladı

Using population health databases from Ontario, Canada, investigators found that children surviving AKI without acute KRT were at higher long-term risk of CKD, long-term KRT, hypertension, and subsequent AKI compared with hospitalized children without AKI bit.ly/JASN0445

JASN_News's tweet image. Using population health databases from Ontario, Canada, investigators found that children surviving AKI without acute KRT were at higher long-term risk of CKD, long-term KRT, hypertension, and subsequent AKI compared with hospitalized children without AKI bit.ly/JASN0445

Loading...

Something went wrong.


Something went wrong.